Europe Positive Airway Pressure (PAP) Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Europe positive airway pressure (PAP) devices market is projected to grow significantly, reaching approximately US$ 2,997.83 million by 2031, up from US$ 1,803.88 million in 2023, reflecting a compound annual growth rate (CAGR) of 6.6% from 2023 to 2031.

Executive Summary and Market Analysis

The market for PAP devices in Europe is divided into several key regions, including Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and Italy are anticipated to hold substantial market shares during the forecast period, while France, the UK, and Spain are expected to present promising growth opportunities. Factors driving this market include an increasing elderly population at higher risk for sleep apnea, a growing acceptance of PAP devices, and a rise in chronic conditions such as chronic obstructive pulmonary disease (COPD) and sleep apnea. Additionally, advancements by companies operating in Europe are contributing to market growth.

Market Segmentation Analysis

The Europe PAP devices market can be categorized based on product type, application, and end user:

Product Type: The market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. In 2023, CPAP devices dominated the market share.
Application: The applications include chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress, with obstructive sleep apnea holding the largest market share in 2023.
End User: The end users are categorized into hospitals, ambulatory surgical centers, home care, and rehabilitation centers, with hospitals leading the market in 2023.

Market Outlook

As awareness of sleep disorders increases, more individuals are seeking medical help for sleep-related issues, leading to a rise in diagnoses and treatments for conditions like obstructive sleep apnea (OSA) through CPAP and BiPAP machines. Public health campaigns by governments and medical organizations are raising awareness about the dangers of untreated sleep apnea, which can lead to serious health issues such as diabetes and cardiovascular diseases. This growing recognition of sleep health is driving demand for PAP devices, as more people are motivated to improve their sleep quality.

World Sleep Day, established in 2008, is an example of an initiative aimed at promoting the importance of healthy sleep and raising awareness about sleep disorders. The theme for 2025, Make Sleep Health a Priority, underscores the significance of prioritizing sleep for overall health. Additionally, campaigns like Speak Up for COPD aim to enhance understanding of COPD and its implications, further increasing the demand for PAP devices as awareness of respiratory diseases grows.

Country Insights

The European PAP devices market includes key countries such as the UK, Germany, France, Spain, Italy, and others. Germany is currently the largest market, driven by its aging population. According to World Population Ageing data, around 28% of Germany's population was aged 60 and above in 2017, a figure projected to rise to approximately 37.6% by 2050. The prevalence of obstructive sleep apnea increases with age, necessitating PAP therapy for many older adults.

In Germany, market players are pursuing organic growth strategies to enhance the PAP devices market. For instance, in September 2023, ResMed Germany partnered with Nyxoah, a company focused on obstructive sleep apnea solutions. This collaboration aims to raise awareness about OSA and promote related therapies, including helplines and marketing efforts targeting ENT specialists and sleep physicians.

Company Profiles

Key players in the PAP devices market include ICU Medical Inc, React Health (formerly 3B Medical, Inc), Fisher & Paykel Healthcare Corp Ltd, BPL Medical Technologies Pvt Ltd, Koninklijke Philips NV, Dragerwerk AG & Co KGaA, ResMed Inc, Vyaire Medical Inc, Wellell Inc, Armstrong Medical Ltd, Löwenstein Medical UK Ltd, BMC Medical Co Ltd, and Narang Medical Limited. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe positive airway pressure (PAP) devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe positive airway pressure (PAP) devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the airway pressure (PAP) devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more